Hepatitis C virus core protein does not inhibit apoptosis in human hepatoma cells

European Journal of Clinical Investigation

Volumn 29, Issue 11, 1999, Pages 940-946

  Dumoulin, Franz Ludwig ^a   Von Dem Bussche, A ^a   Sohne J ^a   Sauerbruch, T ^a   Spengler, U ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; CD95 Fas; Hepatitis C virus; HepG2; Tumour necrosis factor

Indexed keywords

ANTIBODY; CORE PROTEIN; FAS ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; COWPOX VIRUS; DNA TRANSFECTION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CHO CELLS; CRICETINAE; CYCLOHEXIMIDE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, MYC; HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRAL CORE PROTEINS;

EID: 0032739330     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00559.x     Document Type: Article

References (29)

1. 1 Major ME, Feinstone SM. The molecular virology of hepatitis C. Hepatology, 1997;25:1527-37.
2. 2 Spengler U, Lechmann M, Irrgang B, Dumoulin FL, Sauerbruch T. Immune responses in hepatitis C virus infection. J Hepatol, 1996;24 (Suppl. 2):119-25.
3. 3 Barke G. The CTL's kiss of death. Cell, 1995;81:9-12.
4. 4 Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci USA, 1996;93:2239-44.
5. 5 Nagata S. Apoptosis by death factor. Cell, 1997;88:355-65.
6. 6 Shinagawa T, Yoshioka K, Kakumu S et al. Apoptosis in cultured rat hepatocytes: effects of tumour necrosis factor alpha and interferon gamma. J Pathol, 1991;165:253-7.
7. 7 Ogasawara J, Watanabe-Fukunaga R, Adachi M et al. Lethal effect of the anti-Fas antibody in mice. Nature, 1993;364:806-9.
8. 8 Wong GHW, Goeddel DV. Fas antigen and p55 TNF receptor signal apoptosis through different pathways. J Immunol, 1994;152:1751-5.
9. 9 Natoli G, Ianni A, Costanzo A et al. Resistance to fas-mediated apoptosis in human hepatoma cells. Oncogene, 1995;11:1157-64.
10. 10 Galle PR, Hofmann WJ, Walczak H et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med, 1995;182:1223-30.
11. 11 Hiramatsu N, Hayashi N, Katayama K et at. Immunohistochemical detection of fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology, 1994;19:1354-9.
12. 12 Mita E, Hayashi N, Iio S et al. Rule of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun, 1994;204:468-74.
13. 13 Lau JY, Xie X, Lai MM, Wu PC. Apoptosis and viral hepatitis. Semin Liver Dis, 1998;18:169-76.
14. 14 Shen Y, Shenk T. Viruses and apoptosis. Curr Opin Genet Dev, 1994;5:105-11.
15. 15 Teodoro JG, Branton PE. Regulation of apoptosis by viral gene products. J Virol, 1997;71:1739-46.
16. 16 Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumourigenic phenotype. J Virol, 1996;70:4438-43.
17. 17 Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol, 1998;72:3060-5.
18. 18 Ray RB, Steele R, Meyer K, Ray R. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem, 1997;272:10983-6.
19. 19 Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nature Med, 1998;9:1065-7.
20. 20 Ray RB, Meyer K, Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology, 1996;226:176-82.
21. 21 Moradpour D, Wakita T, Tokushige K, Carlson RI, Krawczynski K, Wands JR. Characterization of three novel monoclonal antibodies against hepatitis C virus core protein. J Med Virol, 1996;48:234-41.
22. 22 Dobbelstein M, Shenk T. Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. J Virol, 1996;70:6479-85.
23. 23 Ray RB, Lagging LM, Meyer K, Steele R, Ray R. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res, 1995;37: 209-20.
24. 24 Ray CA, Black RA, Krouheim SR et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell, 1992;69:597-604.
25. 25 Tewari M, Dixit VM. Fas-and tumour necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem, 1995,270:3255-60.
26. 26 Ruggieri A, Harada T, Matsuura Y, Miyamura T. Sensitization to fas-mediated apoptosis by hepatitis C virus core protein. Virology, 1997;229:68-76.
27. 27 Chen C, You LR, Hwang LH, Lee YH. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor. J Virol, 1997;71:7417-26.
28. 28 Zhu N, Khoshnan A, Schneider R et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumour necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol, 1998;72:3691-7.
29. 29 Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R. Inhibition of tumour necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem, 1998;273:2256-9.